Stock futures are pointing higher, buoyed by optimism that President Donald Trump and Xi Jinping will soon reach a trade framework. The tech sector is leading the charge again, with chips and growth names gaining.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Yet, the rally is carrying overtones of caution. Commodity prices, especially gold and copper, are pointing to some rotation out of safe-havens into risk assets.
With central banks in the U.S., Canada, Japan and Eurozone entering key decision windows this week, markets are watching closely for any policy surprises.
In pre-market trading, S&P 500 futures rose 0.10%, Nasdaq futures rose 0.16% and Dow futures rose 0.45%.
Check out this morning’s top movers from around Wall Street, compiled by The Fly.
HIGHER –
- Cameco (CCJ) up 15% after announcing that the United States Government has entered into a strategic partnership to accelerate the deployment of nuclear power that will see at least $80B of new nuclear reactors constructed.
UP AFTER EARNINGS –
- UPS (UPS) up 12%
- PayPal (PYPL) up 12%
- Sherwin-Williams (SHW) up 5%
- UnitedHealth (UNH) up 4%
- Regeneron (REGN) up 3%
- VF Corp. (VFC) up 2%
DOWN AFTER EARNINGS –
- Royal Caribbean (RCL) down 9%
- Corning (GLW) down 6%
- Labcorp (LH) down 2%
- Ecolab (ECL) down 1%
- Tenet Healthcare (THC) down 1%
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCJ:
- Cameco and Brookfield Partner with US Government to Boost Nuclear Reactor Deployment
- Cameco Joins U.S. Government and Partners in $80 Billion Nuclear Power Initiative
- Cameco, Brookfield Asset Management and U.S. government enter nuclear power pact
- Cameco price target raised to C$130 from C$118 at Raymond James
- Trump Trade: President announces $15B libel suit against NY Times
